Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Study limitation reported by the research below: “The trial also enrolled Crohn's disease patients (per the RELIEVE UCCD trial name and a companion paper cited), but this abstract and summary pertain only to the ulcerative colitis cohort.”